Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **central nervous system respiratory centers** are located mainly in the medulla oblongata and pons of the brainstem. These centers include the dorsal and ventral respiratory groups in the medulla and the pneumotaxic and apneustic centers in the pons, all of which collectively generate and adjust the basic rhythm and depth of breathing in response to physiological needs[5][1][7]. They receive input from **central chemoreceptors**, which are specialized neurons on the ventral surface of the medulla (notably the retrotrapezoid nucleus and related areas) that sense changes in CO₂ and pH in the cerebrospinal fluid[2][8][10][4]. These chemoreceptors provide essential feedback to the respiratory centers, leading to increased ventilation when CO₂ rises and pH drops, and reduced ventilation when CO₂ is low. The overall system ensures homeostatic maintenance of blood gases and is crucial for survival. Pathological depression of this system, especially by drugs or brain injury, is life-threatening. This term does not refer to a single molecular entity but describes a complex, distributed neural substrate integrating chemical, mechanical, and higher-order CNS input to control breathing[5][2][4][9][8].
Opioids: Activate μ-opioid receptors on brainstem respiratory neurons, inhibiting neuronal firing and reducing ventilatory drive Anesthetics: General CNS inhibition, including at the medullary and pontine respiratory centers Doxapram: Stimulates chemoreceptors and respiratory centers, increasing respiratory rate Acetazolamide: Induces mild metabolic acidosis, indirectly stimulating the brainstem respiratory centers via chemoreceptor activation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system respiratory center and brainstem chemoreceptor (None (no widely accepted standard abbreviation for the combined entity; individual centers may be abbreviated, e.g., DRG for dorsal respiratory group, VRG for ventral respiratory group, RTN for retrotrapezoid nucleus)).